NULLIFY 2027 / Speakers & scientific committee

12–14 July 2027 · Hilton Singapore Orchard · Singapore

Speakers & scientific committee.

Meet the published faculty contributing perspectives from vaccine immunology, development, regulation and global health. This directory updates directly from the NULLIFY 2027 dashboard.

Scientific leadership

Scientific committee.

Committee members are listed when published by the organising team. Additional members will be announced as confirmed.

Prof James Beeson

Prof James Beeson

Deputy Director, Research Strategy; Head, Malaria Immunity and Vaccines Group

Burnet Institute

Prof Sylvie Alonso

Prof Sylvie Alonso

Professor Department of Microbiology and Immunology

National University of Singapore

Published faculty

Meet the NULLIFY 2027 speakers.

Listed alphabetically by first name. Affiliations and available biographies are supplied through the event dashboard. Publication in the roster does not confirm a particular talk title or session allocation; consult the tentative programme for proposed placements.

Prof Alessandro Sette

Prof Alessandro Sette

Professor and Member, Co-Director LJI Center for Vaccine Innovation, LJI Center for Autoimmunity and Inflammation, LJI Center for Cancer Immunotherapy, Adjunct Prof., University of California, School of Medicine, La Jolla Institute for Immunology

Prof Anthony Cunningham

Prof Anthony Cunningham

Director, Centre for Virus Research, The Westmead Institute for Medical Research​ Professor, Faculty of Medicine and Health, University of Sydney

Prof Beate Kampmann

Prof Beate Kampmann

Director of the Institute of International Health and Scientific Director of the Charité Centre for Global Health at Charité, Universitätsmedizin Berlin

Dr Carolien van de Sandt

Dr Carolien van de Sandt

Team Leader & Senior Research Fellow, Murdoch Children's Research Institute (MCRI); Honorary Senior Research Fellow, University of Melbourne

Dr Chan Kuan Rong

Dr Chan Kuan Rong

Senior Principal Research Scientist, Duke-NUS Medical School

Dr Christopher Locher

Dr Christopher Locher

CEO and Co-Founder, Versatope Therapeutics

Prof Clare Bryant

Prof Clare Bryant

Professor of Innate Immunity, University of Cambridge

Prof Dan Hung Barouch

Prof Dan Hung Barouch

William Bosworth Castle Professor of Medicine, Harvard University

Dr Giada Mattiuzzo

Dr Giada Mattiuzzo

Head of Viral Vaccines, R&D, Medicines and Healthcare products Regulatory Agency

Prof Guido Grandi

Prof Guido Grandi

Senior Professor of Microbiology and Clinical Microbiology, Università degli Studi di Trento

Prof Guido Silvestri

Prof Guido Silvestri

Professor & Chair, Department of Pathology and Laboratory Medicine, Emory University

Prof Ian Wilson

Prof Ian Wilson

Hansen Professor of Structural Biology, Chairman Department of Integrative Structural and Computational Biology, Scripps Research

Dr Jacob Glanville

Dr Jacob Glanville

Chief Executive Officer & President, Centivax

Prof James Beeson

Prof James Beeson

Deputy Director, Research Strategy; Head, Malaria Immunity and Vaccines Group; Burnet Institute

Prof Jonathan Heeney

Prof Jonathan Heeney

CSO, DIOSynVax

Prof Justin Jang Hann CHU

Prof Justin Jang Hann CHU

Assistant Dean for NUS Medicine Academic Affairs, Director for NUS Medicine BSL3 Facility, Associate Professor, Laboratory of Molecular RNA Virology and Antiviral Strategies, Dept of Microbiology and Immunology, Yong Loo Lin School of Medicine, NUHS

Dr Kate Broderick

Dr Kate Broderick

Chief Scientific and Innovation Officer, Artis BioSolutions

Prof Ken J. Ishii

Prof Ken J. Ishii

Professor, Division of Vaccine Science, Department of Microbiology and Immunology, University of Tokyo

Dr Kevin John Selva

Dr Kevin John Selva

Research Fellow, University of Melbourne

Prof Laurent Renia

Prof Laurent Renia

Professor of Infectious Diseases, Lee Kong Chian School of Medicine, Nanyang Technological University

Prof Linfa WANG

Prof Linfa WANG

Professor, Programme in Emerging Infectious Disease, Duke-NUS Medical School

Prof Maria Elena Bottazzi

Prof Maria Elena Bottazzi

Professor, Departments of Pediatrics (Tropical Medicine) and Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences Program, and Translational Biology and Molecular Medicine Program, Baylor College of Medicine

Prof Mark K. Slifka

Prof Mark K. Slifka

President & CSO,Najít Technologies, Inc.

Prof Michela Locci

Prof Michela Locci

Associate Professor, University of Pennsylvania

Prof Pamela J. Bjorkman

Prof Pamela J. Bjorkman

David Baltimore Professor of Biology and Biological Engineering; Merkin Institute Professor, Caltech

Prof Peter McIntyre

Prof Peter McIntyre

Professor and Head of Department of Paediatrics and Child Health, University of Otago

Prof Peter Openshaw

Prof Peter Openshaw

Professor of Experimental Medicine, National Heart &Lung Institute, Imperial College London

Dr Pirouz Daftarian

Dr Pirouz Daftarian

Founder and Director, Innate and Adaptive

Prof Rino Rappuoli

Prof Rino Rappuoli

Scientific Director, Fondazione Biotecnopolo di Siena

Prof Shane Crotty

Prof Shane Crotty

Professor & Chief Scientific Officer (CSO) | La Jolla Institute for Immunology (LJI)

Prof Sylvie Alonso

Prof Sylvie Alonso

Professor Department of Microbiology and Immunology, National University of Singapore

Prof Thomas J. Webster

Prof Thomas J. Webster

Professor, Division of Pre-College and Undergraduate Studies, Brown University

Prof Vineet D. Menachery

Prof Vineet D. Menachery

Associate Professor Department of Pediatrics Emory Vaccine Center Member Emory University School of Medicine

Dr Wayne Koff

Dr Wayne Koff

Managing Partner, Next Frontier Advisors

Explore the science behind the summit.

Review the programme across immunology, vaccine engineering, clinical evidence, regulation and global health. Speaker application proposals are reviewed by the organising team.